HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368,336 | -6.9% | 11,240 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $395,536 | -53.0% | 11,240 | -56.4% | 0.01% | -50.0% |
| Q1 2023 | $841,489 | -40.7% | 25,773 | 0.0% | 0.02% | -42.9% |
| Q4 2022 | $1,420,093 | +25.2% | 25,773 | +0.8% | 0.03% | +21.7% |
| Q3 2022 | $1,134,000 | +11.6% | 25,577 | +22.8% | 0.02% | +27.8% |
| Q2 2022 | $1,016,000 | +4.2% | 20,822 | +4.0% | 0.02% | +20.0% |
| Q1 2022 | $975,000 | +36.7% | 20,023 | +19.7% | 0.02% | +66.7% |
| Q4 2021 | $713,000 | – | 16,721 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |